久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Drugmakers step up efforts for innovative product R&D

By ZHENG YIRAN | China Daily | Updated: 2020-06-30 09:29
Share
Share - WeChat
Visitors make inquiries at the stand of Bristol-Myers Squibb during the second China International Import Expo in Shanghai on Nov 9, 2019. [Photo/LYU LIANG FOR CHINA DAILY]

Favorable policies spur transformation as profit margins for generic drugs shrink

Pharmaceutical enterprises from home and abroad are stepping up efforts in innovative drug research and development as the domestic innovation environment constantly improves and profit margins for generic drugs gradually shrink, said industry experts.

Zhang Lichao, a senior researcher at Guosen Securities, said both domestic and international pharmaceutical firms in China are undergoing innovative transformation. They have stronger innovation momentum, and have been constantly expanding investment in R&D.

"With favorable policies for innovative drugs and reducing profits for generic drugs, innovation has become the only way for the development of high-quality pharmaceutical enterprises," Zhang said.

On June 11, United States-based biopharmaceutical giant Bristol-Myers Squibb unveiled a new corporate brand in China after its integration with US-based biotech company Celgene in November. BMS also announced its new strategy on the Chinese mainland, in which it plans to introduce up to 30 innovative products or indications to the market in the coming five years, many of which have potential to become first-in-class or best-in-class.

Chen Siyuan, president of BMS Chinese mainland and Hong Kong, said: "BMS has the world's most cutting-edge technology and R&D platform, with leading drug R&D capabilities in three major areas: chemistry, biologics and cell therapy. China is one of BMS' most important R&D, manufacturing, commercial and innovation centers. In the future, we will continue to focus on bringing innovative medicines to patients with cancer and other serious diseases."

In addition, the company is focused on cultivating a culture that encourages and recognizes innovation, and nurturing Chinese executives who have a deep understanding of the market with clear vision and global perspectives.

Domestic pharmaceutical firms are also taking action. Chongqing Pharscin Pharmaceutical Co Ltd announced that it would boost drug innovation, and has introduced a chief science officer, an innovative drug business unit, innovative drug labs and an innovative drug team.

Hangzhou, Zhejiang-province-based Yifan Pharmaceutical Co Ltd also launched a small module chemicals business unit to bring about small module innovative drugs.

A China Securities report showed that in the past five years, among the top-10 frequently used drug categories in Chinese hospitals, innovative drugs are taking an increasing percentage. One supportive policy behind this is the centralized generic drug procurement policy, which effectively lowered generic drug prices and decreased their profit margins. The medical insurance negotiation also sped up the inclusion of innovative drugs into medical insurance reimbursement, promoting the rapid increase of innovative drug penetration.

"These policies made pharmaceutical enterprises' pursuit of an innovation development path an inevitable trend. In the past two years, there was an obvious growth in R&D expenditure in the chemical and pharmaceutical sector," said the report.

In 2019, most of the leading chemical and pharmaceutical enterprises in China increased their R&D investment. The growth rate of R&D spending was higher than that of the sector's overall income, the China Securities report added.

1 2 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: freex性日韩| 国产成人偷拍 | 一级女人毛片 | 在线不卡亚洲 | 亚洲男人天 | 欧美一级毛片免费看高清 | 国产八区 | 99热久久免费精品首页 | av亚洲男人天堂 | 国产一级黄色 | 日本人在线看片 | 欧洲一级鲁丝片免费 | 日本69色视频在线观看 | 免费观看欧美一级片 | 亚洲一区在线观看视频 | 毛片基地看看成人免费 | 亚洲欧美韩日 | 九九99九九在线精品视频 | 日本一区不卡视频 | 日本在线 | 中文 | 国产亚洲精品午夜一区 | 成年人免费看视频 | 天堂8资源在线官网资源 | 国产成综合 | 日本高清在线精品一区二区三区 | 国产精品久久精品视 | 日韩精品一区二区三区免费观看 | 亚洲天堂在线观看视频 | 亚洲第一se情网站 | 久久成人免费大片 | 美女张开双腿让男人桶视频免费 | 香蕉久久综合精品首页 | 九九九九在线精品免费视频 | 女人张开双腿让男人桶爽免 | 国产精品资源手机在线播放 | 在线视频 中文字幕 | 成熟性xxxxx 成网站在线观看人免费 | 99久久精品免费观看区一 | 成人精品视频 | 日本免费二区三区久久 | 亚洲国产精品久久久久 |